Article
Upregulation of SOX12 is correlated with poor prognosis and immune infiltrates in skin cutaneous melanoma
2023-03-17
Abstract excerpt
<h4>Background: </h4> Skin cutaneous melanoma (SKCM) is the deadliest form skin cancer worldwide. Tumor immunotherapy has become a new strategy for tumor treatment, particularly for highly metastatic malignant tumors. However, there are no effective biomarkers for immunotherapy in patients with SKCM. As a crucial transcription factor, sex-determining region Y-box 12 ( SOX12 ) plays a critical role in tumorigenesis...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ead849b2-cc6a-5e06-a0c4-caa332e3a4fb
- DOI
- 10.21203/rs.3.rs-2689323/v1
